Results for tag: "Reproterol"

Reproterol is a bronchodilator drug used to treat respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is a long-acting beta-2 agonist (LABA) that works by relaxing the muscles in the airways, allowing more air to flow in and out of the lungs. Reproterol is often used in combination with an inhaled corticosteroid (ICS) to provide better control of symptoms. It is available in both oral and inhaled forms, and is usually taken twice a day. Reproterol is a popular choice for treating respiratory diseases due to its effectiveness and long-lasting effects. It is generally well-tolerated, with few side effects. However, it should not be used in patients with certain medical conditions, such as heart disease or diabetes. The Reproterol market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more